Paras Healthcare has raised ₹652.5 crore from institutional investors through its anchor book ahead of its ₹1,450 crore initial public offering (IPO), scheduled to open on October 21, 2026. The Gurugram-based hospital chain allotted 94.15 lakh equity shares to 21 institutional investors on October 19, attracting participation from global investment firms, domestic mutual funds and insurance companies. The IPO price band has been fixed at ₹660–₹693 per share, with the public subscription window closing on October 23.
The offering combines a ₹500 crore fresh issue with a ₹950 crore offer for sale (OFS) by existing shareholders. Paras Healthcare plans to use part of the fresh capital to repay outstanding borrowings, while its expansion strategy includes new hospitals in Gurugram and Ludhiana. The company currently operates eight hospitals with a total capacity of 2,211 beds. Its IPO comes as hospital operators seek to expand capacity and meet demand for specialised healthcare services, but investors will need to assess the company’s financial performance, debt levels, expansion costs and valuation before making investment decisions.
Key Takeaways
- Anchor funding: Paras Healthcare raised ₹652.5 crore from institutional investors on October 19.
- IPO size: The company aims to raise ₹1,450 crore through its public offering.
- Price band: Shares are priced between ₹660 and ₹693.
- Subscription dates: The IPO opens on October 21 and closes on October 23, 2026.
- Issue structure: The offering includes a ₹500 crore fresh issue and a ₹950 crore OFS.
- Debt repayment: Part of the fresh issue proceeds will be used to repay borrowings.
- Expansion plans: Paras aims to add hospitals in Gurugram and Ludhiana and increase total bed capacity to 3,011 by March 2028.
Paras Healthcare IPO: Key Details
Paras Healthcare’s IPO is a book-built issue, meaning the final offer price is determined through investor demand within the announced price band, subject to the applicable process.
| IPO detail | Information |
|---|---|
| Company | Paras Healthcare Ltd. |
| Total issue size | ₹1,450 crore |
| Fresh issue | ₹500 crore |
| Offer for sale | ₹950 crore |
| Price band | ₹660–₹693 per share |
| Anchor book raised | ₹652.5 crore |
| Anchor allocation | 94.15 lakh shares to 21 investors |
| IPO opening date | October 21, 2026 |
| IPO closing date | October 23, 2026 |
| Stock exchanges | NSE and BSE |
| Lead managers | JM Financial, BofA Securities India and Nuvama Wealth Management |
The ₹1,450 crore issue includes both new shares issued by the company and shares sold by existing shareholders. This distinction is important because the two components serve different purposes: the fresh issue brings capital into Paras Healthcare, while the OFS proceeds go to the shareholders selling their holdings.
Who Invested in the ₹652.5 Crore Anchor Book?
Paras Healthcare’s anchor book attracted 21 institutional investors, including several prominent global investment organisations. The company allotted 94.15 lakh equity shares before the public issue opened.
Investors participating in the anchor allocation included the Abu Dhabi Investment Authority, BlackRock Global Funds, Eastspring Investments, Norway’s Government Pension Fund Global, Natixis International Funds, Integrated Core Strategies (Asia) and Citigroup Global.
Domestic institutions also participated. The company allocated 55.55 lakh shares worth ₹385 crore to nine domestic mutual funds through 24 schemes. These included SBI Mutual Fund, HDFC Asset Management Company, ICICI Prudential Mutual Fund, Kotak Mahindra Mutual Fund, WhiteOak Capital, Motilal Oswal Asset Management, Edelweiss, Baroda BNP Paribas Mutual Fund and ITI Mutual Fund.
Insurance companies also took part in the anchor book. ICICI Prudential Life Insurance, Edelweiss Life Insurance and Canara HSBC Life Insurance acquired a combined 6.49 lakh shares worth ₹45 crore.
Anchor allocations can provide an early indication of institutional participation in an IPO. However, they do not guarantee that the public offering will be fully subscribed, that the shares will list at a premium or that investors will earn a positive return.
How the IPO Proceeds Will Be Used
The offering is divided into two components with different financial implications.
| Component | Amount | Purpose |
|---|---|---|
| Fresh issue | ₹500 crore | Capital raised by Paras Healthcare |
| Offer for sale | ₹950 crore | Proceeds for selling shareholders |
| Total IPO | ₹1,450 crore | Combined offering size |
Paras Healthcare intends to use ₹375 crore of the net proceeds from the fresh issue to repay or prepay a portion of its borrowings. The remaining fresh issue proceeds are earmarked for general corporate purposes and other uses described in the offer documents.
Reducing debt can help a hospital operator manage interest expenses and strengthen its balance sheet. Hospitals require significant capital for land, buildings, medical equipment, staffing and ongoing maintenance. Borrowings can help fund expansion, but they also create repayment obligations that must be met even when patient volumes fluctuate.
The planned repayment is therefore an important part of the IPO’s financial rationale. Investors should also consider the company’s total outstanding debt, borrowing costs, cash flows and future capital expenditure to understand how much financial flexibility the repayment could create.
The ₹950 crore OFS is different. Promoter Dharminder Kumar Nagar plans to sell shares worth ₹300 crore, while Commelina, an affiliate of private equity investor Creador, plans to sell shares worth ₹650 crore.
Because these are secondary share sales, the proceeds go to the selling shareholders rather than directly funding Paras Healthcare’s operations. The distinction matters when assessing how much new capital the company will actually receive from the listing.
Paras Healthcare’s Hospital Network and Expansion Plans
Paras Healthcare operates eight hospitals across northern and eastern India, with a total capacity of 2,211 beds as of March 31, 2026. The company provides tertiary and quaternary healthcare services, which generally involve advanced medical treatment, specialist care and complex procedures.
Its network serves markets including Haryana, Bihar and Jharkhand, with its expansion strategy focused on increasing capacity in existing and new locations.
The company plans to add a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana. The Gurugram facility is expected to become operational in the current financial year, while the Ludhiana project is expected to open in the following financial year.
According to the company’s red herring prospectus, Paras Healthcare expects to increase its total bed capacity to 3,011 by March 2028.
| Capacity indicator | Beds |
|---|---|
| Existing hospital capacity | 2,211 |
| Planned Gurugram hospital | 300 |
| Planned Ludhiana hospital | 500 |
| Expected total capacity by March 2028 | 3,011 |
The planned expansion represents an increase of approximately 36% over current bed capacity. The difference between the total planned capacity and existing capacity is 800 beds, matching the combined capacity of the two proposed hospitals.
However, additional beds do not automatically translate into higher profits. New hospitals typically require upfront investment, recruitment, equipment installation, regulatory clearances and time to build patient volumes. Revenue growth will depend on occupancy, treatment mix, doctor availability and operating efficiency.
Why India’s Hospital Sector Is Attracting Investment
India’s healthcare market is supported by demand for specialised treatment, a growing need for hospital capacity and increasing access to private healthcare services. In many regions, hospitals are investing in advanced diagnostics, cancer treatment, cardiac care, critical care and other specialist services.
Expanding hospital networks can help operators serve more patients and distribute certain administrative and procurement costs across multiple facilities. Larger networks may also be able to develop specialist centres and attract doctors across different locations.
However, healthcare is a capital-intensive business. Hospitals need expensive medical equipment, qualified clinical staff, reliable infrastructure and consistent compliance with healthcare regulations. Their financial performance can vary substantially depending on location, specialty mix and the maturity of individual facilities.
For Paras Healthcare, the planned new hospitals could expand its regional presence and increase its ability to serve patients. The challenge will be to commission facilities on schedule, attract patients and manage costs as the new hospitals move toward stable utilisation.
The IPO gives the company an opportunity to raise capital and reduce some debt, but investors will still need to evaluate how effectively management executes its expansion plans.
What Investors Should Evaluate Before the IPO
The anchor book provides information about institutional participation, but an investment decision requires a broader review of the company’s financial and operational profile.
First, investors should examine revenue growth and profitability. Hospital operators can report increasing revenue while facing pressure from salaries, consumables, maintenance, equipment depreciation and interest expenses.
Second, debt and cash flow deserve attention. The planned ₹375 crore repayment may reduce borrowing costs, but the extent of the benefit depends on the company’s overall debt position and the financing required for future hospitals.
Third, investors should assess expansion risks. New facilities can increase capacity and future revenue potential, but they may initially operate below their eventual occupancy levels. Delays or cost overruns can affect returns on invested capital.
Fourth, valuation matters. The IPO price band of ₹660–₹693 should be considered alongside the company’s earnings, cash generation, debt, growth prospects and comparable listed hospital operators. Institutional participation alone does not establish that the offer price is attractive.
Finally, investors should read the red herring prospectus, including the risk factors and use-of-proceeds disclosures. The company itself has cautioned in its offer documents that the offer price should not be taken as an indication of the share’s market price after listing.
The Bigger Picture
Paras Healthcare’s anchor book demonstrates that institutional investors are participating in its upcoming IPO, while the public offering provides a route to raise fresh capital and allow existing shareholders to sell part of their holdings. The company’s plans to repay debt and add 800 beds through new hospitals give the offering both a balance-sheet component and a longer-term growth story.
The investment case will ultimately depend on more than the anchor allocation. Paras Healthcare must translate expansion plans into patient volumes, manage the costs of new facilities and maintain financial discipline. Investors will need to weigh those opportunities against execution risks, debt obligations and the valuation implied by the IPO price band.
Looking Ahead
The Paras Healthcare IPO opens on October 21 and closes on October 23, 2026. Investors will watch subscription levels across retail, non-institutional and institutional categories, along with the final allocation and listing timetable. The anchor book is an early indicator of participation, but demand from the broader market will provide a more complete picture of investor appetite for the offering.
After listing, attention will shift to the use of fresh issue proceeds, debt repayment and progress on the Gurugram and Ludhiana projects. The company’s ability to increase capacity while maintaining occupancy, profitability and cash flow will be central to its long-term performance. The planned increase to 3,011 beds by March 2028 is a target, and its delivery will depend on construction, staffing, approvals and demand.
Frequently Asked Questions
1. How much has Paras Healthcare raised from anchor investors?
Paras Healthcare raised ₹652.5 crore through its anchor book on October 19, 2026, allotting 94.15 lakh shares to 21 institutional investors.
2. When does the Paras Healthcare IPO open?
The IPO opens on October 21, 2026, and closes on October 23, 2026.
3. What is the price band for the Paras Healthcare IPO?
The price band is ₹660–₹693 per equity share.
4. How will Paras Healthcare use the IPO proceeds?
The company plans to use ₹375 crore from the net fresh issue proceeds to repay or prepay part of its borrowings. The remaining fresh issue proceeds will be used for general corporate purposes and other uses specified in the offer documents. The OFS proceeds go to selling shareholders.
5. How many hospitals does Paras Healthcare operate?
Paras Healthcare operates eight hospitals with a total capacity of 2,211 beds, according to the reported figures as of March 31, 2026.
6. What are Paras Healthcare’s expansion plans?
The company plans to add a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana. It expects total bed capacity to reach 3,011 by March 2028, subject to execution of the projects.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
